On the mode of action of mirabegron
Crossref DOI link: https://doi.org/10.1038/nrurol.2015.297
Published Online: 2015-12-15
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Andersson, Karl-Erik
Text and Data Mining valid from 2015-12-15
Article History
First Online: 15 December 2015
Competing interests
: K-E.A. declares that he is a consultant and/or on the advisory board for Allergan, Astellas and Ferring.